
AFT Pharmaceuticals Limited Investor Relations Material
Latest events

AGM 2025
AFT Pharmaceuticals Limited
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AFT Pharmaceuticals Limited
Access all reports
AFT Pharmaceuticals Limited is a New Zealand-based pharmaceutical company that develops, licenses, and distributes a range of pharmaceutical products across Australasia and other international markets. The company’s portfolio includes over-the-counter medicines, prescription drugs, and specialty products, with a focus on pain management, allergy relief, and respiratory health. AFT Pharmaceuticals combines in-house research and development with strategic partnerships to bring innovative treatments to market, aiming to address unmet medical needs and improve patient outcomes. The company is headquartered in Auckland, New Zealand, and its shares are listed on the NZX and ASX.
Key slides for AFT Pharmaceuticals Limited


H2 2025
AFT Pharmaceuticals Limited


AGM 2025
AFT Pharmaceuticals Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
AFT
Country
🇳🇿 New Zealand